Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT06167629
Overview
The general objective of this retrospective and prospective study is to evaluate the diagnostic and prognostic role of a quantitative analysis of PET images with 18F-PSMA in all stages of the disease in patients with prostate cancer. To this end, both imaging parameters commonly used in clinical practice and the contribution of radiomic features will be investigated. The latter are quantitative features extracted from biomedical images, and are believed to be able to provide information, otherwise impossible to investigate, useful for the characterization of various pathologies. This methodology is very promising, but also recent and therefore little studied and standardized. Our objective is also to investigate how to optimize it from a purely methodological point of view.
Sponsor
IRCCS San Raffaele
Phase
N/A
Contacts
Arturo Chiti
chiti.arturo@hsr.it
0226432716
Alessandra Maielli
maielli.alessandra@hsr.it
0226432716
ClinicalTrials.gov
NCT06167629Drug / Compound
Help us improve your experience